HOME >> BIOLOGY >> NEWS
Leading experts in field of gene therapy to meet in Minneapolis

The leading experts in the field of gene therapy will gather in Minneapolis, June 2-6, 2004, for the 7th Annual Meeting of the American Society of Gene Therapy (ASGT). New developments on the use of gene therapy for treating infections diseases such as cancer and AIDS, cardiovascular diseases, and cystic fibrosis will be showcased in a variety of educational workshops and symposia.

Program topics will also feature:

  • Innovative approaches of gene therapy
  • Long term follow up of gene therapy clinical trials
  • International harmonization of regulatory standards for clinical trials

Gordon Keller, MD, Mount Sinai School of Medicine, and Catherine Verfaillie, MD, University of Minnesota Health Center, will present the Presidential Symposium lecture. In addition, the premier George Stamatoyannopoulos lecture will be given by Harriet Robinson, MD, from the Yerkes Regional Primate Research Center.

Members of the media may register without charge for the ASGT 7th Annual Meeting. Press conferences on the latest research will be conducted throughout the meeting. A press room with interview space, computers, modem lines, telephone and facsimile services will also be available onsite for media representatives. To receive an annual meeting preliminary program, press conference schedule, or registration materials, contact John Gardner at 414-278-1341 or jgardner@execinc.com.

The ASGT is the largest medical professional organizations representing researchers and scientists dedicated to discovering new gene therapies. Established in 1996, the ASGT has grown to nearly 3,000 members. ASGT is committed to promoting and fostering the exchange and dissemination of information and ideas related to gene therapy and encouraging the general field of research.

For more information, contact John Gardner at 414/278-1341 or visit www.asgt.org


'"/>

Contact: John Gardner
jgardner@execinc.com
414-278-1341
American Academy of Allergy, Asthma & Immunology
5-Apr-2004


Page: 1

Related biology news :

1. Leading scientists design new framework for biodiversity conservation
2. Leading science, higher-education and engineering groups urge six improvements to U.S. visa quagmire
3. Leading U.S. gun manufacturer joins NJIT to develop personalized handgun
4. Leading bacterial pathogen is sequenced
5. Leading cloning experts challenge Clonaid to prove claim
6. Leading cancer research organization urges FDA to speed approval of drugs for precancers
7. Leading lab expert to update medical community on diagnostic testing for thyroid function
8. Leading indoor environment experts to convene at Syracuse University to discuss air quality and urban environments
9. Leading snake expert dies at 38
10. Leading experts address safety and economics of biotech crops
11. Taking the show on the road - Leading researchers to conduct hands-on science symposium for 500 San Francisco area high school students

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Leading experts field gene therapy meet Minneapolis

(Date:8/25/2015)... LAKE CITY and BELLEVUE, Wash. ... global leader in advanced robotic systems, announced today it ... robotic unmanned ground vehicle (UGV), at the National Tactical ... City.  The Guardian S is the ... the culmination of years of research and in-field trials ...
(Date:8/20/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... the growing mobile commerce market and creator of the ... Card Alliance and the EMV Migration Forum.  ... Card Alliance Latin America (SCALA) Chapter provides NXT-ID, Inc. ... leaders promoting adoption of smart card technology. ...
(Date:8/12/2015)... , Aug. 12, 2015   MedNet Solutions ... the entire spectrum of clinical research, is proud to ... the company,s comprehensive SaaS-based eClinical technology platform, has led ... the first two quarters of 2015.   Q2 2015 ... largest quarters measured by contract value sold in the ...
Breaking Biology News(10 mins):Sarcos to Debut First-of-its-Kind Snake Robot 2Sarcos to Debut First-of-its-Kind Snake Robot 3NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 2NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 3NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 4MedNet Solutions Experiences Explosive Corporate Growth 2
(Date:9/2/2015)... , Sep. 02, 2015 ... announced the addition of Jain PharmaBiotech,s new report ... to their offering. This report follows ... characteristic that can be objectively measured and evaluated ... processes as well as pharmacological responses to a ...
(Date:9/2/2015)... , Sept. 2, 2015  Neurotech Pharmaceuticals, Inc., ... in the multicenter Phase 2 clinical trial of ... treatment of recurrent subfoveal choroidal neovascularization secondary to ... a unique vascular endothelial growth factor (VEGF) receptor ... "This landmark proof-of-concept study will evaluate ...
(Date:9/2/2015)... , September 2, 2015 BiondVax ... of the National Institute of Allergy and Infectious Diseases (NIAID), ... the Department of Health and Human Services (HHS), to launch ... the United States in the 2015-16 timeframe. ... vaccine candidate, Multimeric-001 (M-001), as a primer vaccine, which would ...
(Date:9/2/2015)... ... September 02, 2015 , ... The ... creating professional commercial video content, to analysis of athletic performance. Producing high-resolution ... go by too quickly to process with the naked eye. , Slow ...
Breaking Biology Technology:Updated 2015 Biomarkers Report - Latest Technologies, Markets and Companies Insights to 2024 with over 1,000 References 2Updated 2015 Biomarkers Report - Latest Technologies, Markets and Companies Insights to 2024 with over 1,000 References 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 4BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 2BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 3Fastec Introduces the Quad-HD TS5-Q High-Speed Camera 2Fastec Introduces the Quad-HD TS5-Q High-Speed Camera 3
Cached News: